THE INADEQUATE RESPONSE OF THE FDA TO THE CRISIS OF AIDS IN THE BLOOD SUPPLY

DSpace/Manakin Repository

THE INADEQUATE RESPONSE OF THE FDA TO THE CRISIS OF AIDS IN THE BLOOD SUPPLY

Citable link to this page

. . . . . .

Title: THE INADEQUATE RESPONSE OF THE FDA TO THE CRISIS OF AIDS IN THE BLOOD SUPPLY
Author: Russell, Lisa
Citation: THE INADEQUATE RESPONSE OF THE FDA TO THE CRISIS OF AIDS IN THE BLOOD SUPPLY (1995 Third Year Paper)
Full Text & Related Files:
Abstract: The response of the blood industry and the Food and Drug Administration (FDA) to the problem of acquired immune deficiency syndrome (AIDS) in the nation's blood supply has been called "inadequate and abysmal," "unnecessarily slow," and "woefully inept." During the early 1 980s, the AIDS virus was contaminating our nation's blood supply while the blood industry and the FDA refused to take appropriate steps to stop it--they, quite simply, "failed us." This paper will focus on the time of uncertainty ó the time from when the first AIDS case was diagnosed to the time when AIDS testing became available and widespread. The failure of the FDA to protect the safety of the blood supply during these years will be examined in detail. The sequence of events during these years will be recounted and analyzed to determine exactly what happened, why this breakdown occurred, and what can be done to prevent such failures from occurring in the future.
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:8965576

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters